Despite suggestive early findings on the therapeutic use of hallucinogens in the treatment of substance use disorders, rigorous follow-up has not been conducted. To determine the safety and feasibility of psilocybin as an adjunct to tobacco smoking cessation treatment we conducted an open-label pilot study administering moderate (20 mg/70 kg) and high (30 mg/70 kg) doses of psilocybin within a structured 15-week smoking cessation treatment protocol. Participants were 15 psychiatrically healthy nicotine-dependent smokers (10 males; mean age of 51 years), with a mean of six previous lifetime quit attempts, and smoking a mean of 19 cigarettes per day for a mean of 31 years at intake. Biomarkers assessing smoking status, and self-report measures of smoking behavior demonstrated that 12 of 15 participants (80%) showed seven-day point prevalence abstinence at 6-month follow-up. The observed smoking cessation rate substantially exceeds rates commonly reported for other behavioral and/or pharmacological therapies (typically <35%). Although the open-label design does not allow for definitive conclusions regarding the efficacy of psilocybin, these findings suggest psilocybin may be a potentially efficacious adjunct to current smoking cessation treatment models. The present study illustrates a framework for future research on the efficacy and mechanisms of hallucinogen-facilitated treatment of addiction.

References

Benowitz, NL, Jacob, P, Ahijevych, K. ( 2002 ) Biochemical verification of tobacco use and cessation . Nicotine Tob Res 4: 149 – 159 .

Google Scholar Crossref | Medline

Bogenschutz, MP, Pommy, JM ( 2012 ) Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: From indirect evidence to testable hypotheses . Drug Test Anal 4: 543 – 555 .

Google Scholar Crossref | Medline | ISI

Bowen, WT, Soskin, RA, Chotlos, JW ( 1970 ) Lysergic acid diethylamide as a variable in the hospital treatment of alcoholism: A follow-up study . J Nerv Ment Dis 150: 111 – 118 .

Google Scholar Crossref | Medline

Bramer, SL, Kallungal, BA ( 2003 ) Clinical considerations in study designs that use cotinine as a biomarker . Biomarkers 8: 187 – 203 .

Google Scholar Crossref | Medline | ISI

Cahill, K, Stevens, S, Lancaster, T ( 2014 ) Pharmacological treatments for smoking cessation . JAMA 311: 193 – 194 .

Google Scholar Crossref | Medline | ISI

Carhart-Harris, RL, Erritzoe, D, Williams, T. ( 2012 ) Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin . Proc Natl Acad Sci 109: 2138 – 2143 .

Google Scholar Crossref | Medline | ISI

Carhart-Harris, RL, Leech, R, Tagliazucchi, E. ( 2014 ) The entropic brain: A theory of conscious states informed by neuroimaging research with psychedelic drugs . Front Human Neurosci 8: 1 – 20 .

Google Scholar Crossref | Medline | ISI

Chwelos, N, Blewett, DB, Smith, CM. ( 1959 ) Use of d-lysergic acid diethylamide in the treatment of alcoholism . Quart J Stud Alcohol 20: 577 – 590 .

Google Scholar Medline

Cole, C, Crum, RM, Ford, DE ( 2006 ) Associations between spirituality and substance abuse symptoms in the Baltimore Epidemiologic Catchment Area follow-up, 1993–1996 . J Addict Dis 25: 125 – 132 .

Google Scholar Crossref | Medline | ISI

DiClemente, CC, Prochaska, JO ( 1985 ) Processes and stages of change: Coping and competence in smoking behavior change . In: Shiffman, S, Wills, TA (eds) Coping and Substance Abuse. New York, NY : Academic Press : 319 – 343 .

Google Scholar

DiClemente, CC, Prochaska, JO, Gibertini, M ( 1985 ) Self-efficacy and the stages of self-change of smoking . Cognit Ther Res 9: 181 – 200 .

Google Scholar Crossref | ISI

Fagerström, K ( 2012 ) Determinants of tobacco use and renaming the FTND to the Fagerström Test for Cigarette Dependence . Nicotine Tob Res 14: 75 – 78 .

Google Scholar Crossref | Medline | ISI

Fantegrossi, WE, Woods, JH, Winger, G ( 2004 ) Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys . Behav Pharmacol 15: 149 – 157 .

Google Scholar Crossref | Medline | ISI

First, MB, Spitzer, RL, Gibbon, M, Williams, JB ( 2012 ) Structured Clinical Interview for DSM-IV® Axis I Disorders (SCID-I), Clinician Version, Administration Booklet. American Psychiatric Pub .

Google Scholar

Galanter, M ( 2006 ) Spirituality and addiction: A research and clinical perspective . Am J Addict 15: 286 – 292 .

Google Scholar Crossref | Medline | ISI

Griffiths, RR, Bigelow, GE, Henningfield, JE ( 1980 ) Similarities in animal and human drug-taking behavior . Adv Subst Abuse 1: 1 – 90 .

Google Scholar

Griffiths, RR, Johnson, MW, Richards, WA. ( 2011 ) Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects . Psychopharmacology (Berl) 218: 649 – 665 .

Google Scholar Crossref | Medline | ISI

Griffiths, RR, Richards, WA, Johnson, MW. ( 2008 ) Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later . J Psychopharmacol 22: 621 – 632 .

Google Scholar SAGE Journals | ISI

Griffiths, RR, Richards, WA, McCann, U. ( 2006 ) Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance . Psychopharmacology (Berl) 187: 268 – 283 .

Google Scholar Crossref | Medline | ISI

Gonzales, D, Rennard, SI, Nides, M. ( 2006 ) Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation . JAMA 296: 47 – 55 .

Google Scholar Crossref | Medline | ISI

Grinspoon, L, Bakalar, JB ( 1979 ) Psychedelic drugs reconsidered. New York : Basic Books .

Google Scholar

Grob, CS, Danforth, AL, Chopra, GS. ( 2011 ) Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer . Arch Gen Psychiatry 68: 71 – 78 .

Google Scholar Crossref | Medline

Hall, SM, Humfleet, GL, Muñoz, RF. ( 2009 ) Extended treatment of older cigarette smokers . Addiction 104: 1043 – 1052 .

Google Scholar Crossref | Medline | ISI

Halpern, JH ( 1996 ) The use of hallucinogens in the treatment of addiction . Addict Res Theory 4: 177 – 189 .

Google Scholar Crossref | ISI

Halpern, JH, Pope, HG ( 2003 ) Hallucinogen persisting perception disorder: What do we know after 50 years? Drug Alcohol Depend 69: 109 – 119 .

Google Scholar Crossref | Medline | ISI

Heatherton, TF, Kozlowski, LT, Frecker, RC. ( 1991 ) The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire . Br J Addict 86: 1119 – 1127 .

Google Scholar Crossref | Medline

Hollister, LE, Shelton, J, Krieger, G ( 1969 ) A controlled comparison of lysergic acid diethylamide (LSD) and dextroamphetamine in alcoholics . Am J Psychiatry 125: 1352 – 1357 .

Google Scholar Crossref | Medline | ISI

Hood, RW ( 1975 ) The construction and preliminary validation of a measure of reported mystical experience . J Sci Study Relig 14: 29 – 41 .

Google Scholar Crossref | ISI

Hood, RW, Ghorbani, N, Watson, PJ. ( 2001 ) Dimensions of the mysticism scale: Confirming the three-factor structure in the United States and Iran . J Sci Study Relig 40: 691 – 705 .

Google Scholar Crossref | ISI

Hughes, JR, Keely, JP, Niaura, RS. ( 2003 ) Measures of abstinence in clinical trials: Issues and recommendations . Nicotine Tob Res 5: 13 – 25 .

Google Scholar Crossref | Medline | ISI

Javors, MA, Hatch, JP, Lamb, RJ ( 2005 ) Cut-off levels for breath carbon monoxide as a marker for cigarette smoking . Addiction 100: 159 – 167 .

Google Scholar Crossref | Medline | ISI

Johnson, MW, Richards, WA, Griffiths, RR ( 2008 ) Human hallucinogen research: Guidelines for safety . J Psychopharmacol 22(6): 603 – 620 .

Google Scholar SAGE Journals | ISI

Johnson, MW, Sewell, RA, Griffiths, RR ( 2012 ) Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers . Drug Alcohol Depend 123: 132 – 140 .

Google Scholar Crossref | Medline | ISI

Jorenby, DE, Hays, JT, Rigotti, NA. ( 2006 ) Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation . JAMA 296: 56 – 63 .

Google Scholar Crossref | Medline | ISI

Kabat-Zinn, J ( 1990 ) Full catastrophe living: Using the wisdom of your body and mind to face stress, pain, and illness. New York : Delacorte .

Google Scholar

Killen, JD, Fortmann, SP, Schatzberg, AF. ( 2008 ) Extended cognitive behavior therapy for cigarette smoking cessation . Addiction 103: 1381 – 1390 .

Google Scholar Crossref | Medline | ISI

Krebs, TS, Johansen, PØ ( 2012 ) Lysergic acid diethylamide (LSD) for alcoholism: Meta-analysis of randomized controlled trials . J Psychopharm 26: 994 – 1002 .

Google Scholar SAGE Journals | ISI

Ludwig, A, Levine, J, Stark, L. ( 1969 ) A clinical study of LSD treatment in alcoholism . Am J Psychiatry 126: 59 – 69 .

Google Scholar Crossref | Medline | ISI

Mangini, M ( 1998 ) Treatment of alcoholism using psychedelic drugs: A review of the program of research . J Psychoactive Drugs 30: 381 – 418 .

Google Scholar Crossref | Medline | ISI

Marks, DF ( 1993 ) The QUIT FOR LIFE Programme: An easier way to stop smoking and not start again. Leicester, UK : British Psychological Society .

Google Scholar

Marks, DF, Sykes, CM ( 2002 ) Randomized controlled trial of cognitive behavioural therapy for smokers living in a deprived area of London: Outcome at one-year follow-up . Psychol Health Med 7: 17 – 24 .

Google Scholar Crossref

Middleton, ET, Morice, AH ( 2000 ) Breath carbon monoxide as an indication of smoking habit . Chest 117: 758 – 763 .

Google Scholar Crossref | Medline | ISI

Mottillo, S, Filion, KB, Bélisle, P. ( 2009 ) Behavioural interventions for smoking cessation: A meta-analysis of randomized controlled trials . Eur Heart J 30: 718 – 730 .

Google Scholar Crossref | Medline | ISI

National Institute on Drug Abuse ( 2001 ) Hallucinogens and Dissociative Drugs. National Institute on Drug Abuse research report series, NIH Publication , volume 01–4209; March , 2001 .

Google Scholar

National Institute on Drug Abuse ( 2005 ) LSD NIDA Infofacts. National Institute on Drug Abuse , Rockville, MD ; February , 2005 .

Google Scholar

Nutt, DJ, King, LA, Nichols, DE ( 2013 ) Effects of Schedule I drug laws on neuroscience research and treatment innovation . Nat Rev Neurosci 14: 577 – 585 .

Google Scholar Crossref | Medline | ISI

Osmond, H, Albahary, R, Cheek, F, Sarett, M ( 1967 ) Some problems in the use of LSD 25 in the treatment of alcoholism . In: Abramson, HA (ed) The use of LSD in psychotherapy and alcoholism. Indianapolis, IN : Bobbs-Merrill , 434 – 457 .

Google Scholar

Pahnke, WN, Kurland, AA, Unger, S. ( 1970 ) The experimental use of psychedelic (LSD) psychotherapy . JAMA 212: 1856 – 1863 .

Google Scholar Crossref | Medline | ISI

Perkins, KA, Conklin, CA, Levine, MD ( 2007 ) Cognitive-behavorial therapy for smoking cessation: A practical guidebook to the most effective treatments. New York : Routledge .

Google Scholar

Piderman, KM, Schneekloth, TD, Pankratz, VS. ( 2007 ) Spirituality in alcoholics during treatment . Am J Addict 16: 232 – 237 .

Google Scholar Crossref | Medline | ISI

Piedmont, RL ( 2004 ) Spiritual transcendence as a predictor of psychosocial outcome from an outpatient substance abuse program . Psychol Addict Behav 18: 213 – 222 .

Google Scholar Crossref | Medline | ISI

Poling, A, Bryceland, J ( 1979 ) Voluntary drug self-administration by nonhumans: A review . J Psychoactive Drugs 11: 185 – 190 .

Google Scholar Crossref | ISI

Ross, S ( 2012 ) Serotonergic hallucinogens and emerging targets for addiction pharmacotherapies . Psychiatr Clin North Am 35: 357 – 374 .

Google Scholar Crossref | Medline | ISI

Savage, C, McCabe, OL ( 1973 ) Residential psychedelic (LSD) therapy for the narcotic addict: A controlled study . Arch Gen Psychiatry 28: 808 – 814 .

Google Scholar Crossref | Medline

Shiffman, S, West, RJ, Gilbert, DG ( 2004 ) Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials . Nicotine Tob Res 6: 599 – 614 .

Google Scholar Crossref | Medline | ISI

Smart, RG, Storm, T, Baker, EFW. ( 1966 ) A controlled study of lysergid in the treatment of alcoholism: The effects on drinking behavior . Quart J Stud Alcohol 27: 469 – 485 .

Google Scholar Medline

Sobell, LC, Sobell, MB ( 1992 ) Timeline follow-back: A technique for assessing self-reported alcohol consumption . In: Litten, R, Allen, J (eds) Measuring Alcohol Consumption. Rockville, MD : Humana Press : 207 – 224 .

Google Scholar Crossref

Sykes, CM, Marks, DF ( 2001 ) Effectiveness of a cognitive behaviour therapy self-help programme for smokers in London, UK . Health Promot Int 16: 255 – 260 .

Google Scholar Crossref | Medline | ISI

Tiffany, ST, Drobes, DJ ( 1991 ) The development and initial validation of a questionnaire on smoking urges . Br J Addict 86: 1467 – 1476 .

Google Scholar Crossref | Medline

US Department of Health and Human Services ( 2014 ) The Health Consequences of Smoking: 50 Years of Progress: a Report of the Surgeon General. Atlanta, GA : US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health .

Google Scholar

Vollenweider, FX, Kometer, M ( 2010 ) The neurobiology of psychedelic drugs: Implications for the treatment of mood disorders . Nat Rev Neurosci 11: 642 – 651 .

Google Scholar Crossref | Medline | ISI

Welsch, SK, Smith, SS, Wetter, DW. ( 1999 ) Development and validation of the Wisconsin Smoking Withdrawal Scale . Exp Clin Psychopharmacol 7: 354 – 361 .

Google Scholar Crossref | Medline | ISI

World Health Organization ( 2011 ) WHO report on the global tobacco epidemic, 2011: Warning about the dangers of tobacco. Geneva, Switzerland : World Health Organization .

Google Scholar